多发性硬化症与脱髓鞘疾病：过去、现在与未来。
Multiple Sclerosis and Demyelinating Disorders: Past, Present, and Future.
作者信息
Bakirtzis Christos, Evangelopoulos Maria Elephteria, Grigoriadis Nikolaos
机构信息
Multiple Sclerosis Center, Second Department of Neurology, School of Medicine, Aristotle University of Thessaloniki, 546 21 Thessaloniki, Greece.
First Department of Neurology, Aeginition Hospital, National and Kapodistrian University of Athens, 115 28 Athens, Greece.
出版信息
J Clin Med. 2024 Sep 22;13(18):5621. doi: 10.3390/jcm13185621.
Abstract
In the past two decades, there has been a considerable increase of our knowledge with regards to the pathophysiology and management of various demyelinating diseases of the central nervous system [...].
摘要
在过去二十年里，我们对中枢神经系统各种脱髓鞘疾病的病理生理学和治疗方法的了解有了显著增加。
相似文献
1
Multiple Sclerosis and Demyelinating Disorders: Past, Present, and Future.多发性硬化症与脱髓鞘疾病：过去、现在与未来。
J Clin Med. 2024 Sep 22;13(18):5621. doi: 10.3390/jcm13185621.
2
Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases.五十年的 cuprizone，复制脱髓鞘疾病的更新模型。
Curr Neuropharmacol. 2019;17(2):129-141. doi: 10.2174/1570159X15666170717120343.
3
Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.多发性硬化及相关疾病中的肿胀性脱髓鞘病变
Curr Neurol Neurosci Rep. 2016 Mar;16(3):26. doi: 10.1007/s11910-016-0626-9.
4
Imaging of Central Nervous System Demyelinating Disorders.中枢神经系统脱髓鞘疾病的影像学检查
Continuum (Minneap Minn). 2023 Feb 1;29(1):292-323. doi: 10.1212/CON.0000000000001246.
5
Diagnosis and Management of Central Nervous System Demyelinating Disorders.中枢神经系统脱髓鞘疾病的诊断与治疗。
Neurol Clin. 2022 Feb;40(1):113-131. doi: 10.1016/j.ncl.2021.08.008.
6
Childhood multiple sclerosis and related disorders.儿童多发性硬化症及相关疾病
Oman Med J. 2007 Oct;22(3):11-5.
7
Movement disorders in multiple sclerosis and other demyelinating diseases.多发性硬化症和其他脱髓鞘疾病中的运动障碍。
J Neurol Sci. 2013 May 15;328(1-2):1-8. doi: 10.1016/j.jns.2013.02.007. Epub 2013 Mar 19.
8
[An interpretation of consensus statements on diagnostic criteria for multiple sclerosis and demyelinating diseases of the central nervous system in children (2012 version)].[儿童多发性硬化症及中枢神经系统脱髓鞘疾病诊断标准共识声明解读（2012版）]
Zhongguo Dang Dai Er Ke Za Zhi. 2016 Dec;18(12):1199-1204. doi: 10.7499/j.issn.1008-8830.2016.12.001.
9
Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.四价人乳头瘤病毒疫苗接种与多发性硬化症及其他中枢神经系统脱髓鞘疾病的风险。
JAMA. 2015 Jan 6;313(1):54-61. doi: 10.1001/jama.2014.16946.
10
Genetic Basis of Inflammatory Demyelinating Diseases of the Central Nervous System: Multiple Sclerosis and Neuromyelitis Optica Spectrum.中枢神经系统炎症性脱髓鞘疾病的遗传基础：多发性硬化症和视神经脊髓炎谱系疾病。
Genes (Basel). 2023 Jun 23;14(7):1319. doi: 10.3390/genes14071319.
引用本文的文献
1
Machine Learning Algorithms Introduce Evoked Potentials As Alternative Biomarkers for the Expanded Disability Status Scale Prognosis of Multiple Sclerosis Patients.机器学习算法引入诱发电位作为多发性硬化症患者扩展残疾状态量表预后的替代生物标志物。
Cureus. 2025 Mar 10;17(3):e80335. doi: 10.7759/cureus.80335. eCollection 2025 Mar.
本文引用的文献
1
Perceived usefulness of digital self-tracking among people with multiple sclerosis.多发性硬化症患者对数字自我追踪的感知有用性。
Digit Health. 2024 Aug 5;10:20552076241264389. doi: 10.1177/20552076241264389. eCollection 2024 Jan-Dec.
2
Smouldering-Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions.冒烟型多发性硬化恶化：定义、生物学、临床意义和未来方向的国际共识声明。
Ann Neurol. 2024 Nov;96(5):826-845. doi: 10.1002/ana.27034. Epub 2024 Jul 25.
3
Radiologically isolated syndrome in the spectrum of multiple sclerosis.多发性硬化症谱系中的放射学孤立综合征。
Mult Scler. 2024 May;30(6):630-636. doi: 10.1177/13524585241245306. Epub 2024 Apr 15.
4
Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management.神经丝轻链作为多发性硬化症管理中脑脊液和血液生物标志物的使用指南。
EBioMedicine. 2024 Mar;101:104970. doi: 10.1016/j.ebiom.2024.104970. Epub 2024 Feb 13.
5
Etiology, effects and management of comorbidities in multiple sclerosis: recent advances.多发性硬化症共病的病因、影响和管理：最新进展。
Front Immunol. 2023 May 30;14:1197195. doi: 10.3389/fimmu.2023.1197195. eCollection 2023.
6
Updates and advances in multiple sclerosis neurotherapeutics.多发性硬化症神经治疗学的最新进展。
Neurodegener Dis Manag. 2023 Feb;13(1):47-70. doi: 10.2217/nmt-2021-0058. Epub 2022 Oct 31.
7
Towards a global view of multiple sclerosis genetics.迈向多发性硬化症遗传学的全球视野。
Nat Rev Neurol. 2022 Oct;18(10):613-623. doi: 10.1038/s41582-022-00704-y. Epub 2022 Sep 8.
8
The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis.分子影像学在多发性硬化症中的髓鞘修复和再生标志物中的作用。
Int J Mol Sci. 2021 Dec 31;23(1):474. doi: 10.3390/ijms23010474.
9
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.多发性硬化症基因组图谱提示外周免疫细胞和小胶质细胞与易感性有关。
Science. 2019 Sep 27;365(6460). doi: 10.1126/science.aav7188.
10
Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.放射学孤立综合征或亚临床多发性硬化症：MAGNIMS共识推荐
Mult Scler. 2018 Feb;24(2):214-221. doi: 10.1177/1352458517717808.
Zotero 插件